Skip to main content
. 2014 Feb 12;39(7):1654–1663. doi: 10.1038/npp.2014.12

Table 1. Study Design.

  Session 1 Session 2 Session 3 Session 4
Capsule Placebo Placebo 0.75 mg/kg MDMA 1.5 mg/kg MDMA
Intranasal spray Placebo 20 or 40 IU Oxytocin Placebo Placebo

The order of drugs was randomized across subjects. All participants received both doses of MDMA and placebo, and one active oxytocin dose (20 IU (N=43) or 40 IU (N=22)).